About the advantages and disadvantages of discrete-event simulation for health economic analyses

  • Mondher Toumi, Ekkehard Beck, Steve Sherman, Leyla Mohseninejad, Samuel Aballéa
  • Expert Review of Pharmacoeconomics & Outcomes Research, November 2016, Taylor & Francis
  • DOI: 10.1080/14737167.2016.1259572

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/14737167.2016.1259572